Bacterial Blood Stream Infections Negatively Impact on Outcome of Patients Treated with Allogeneic Stem Cell Transplantation: 6 Years Single-Centre Experience
- PMID: 28698779
- PMCID: PMC5499498
- DOI: 10.4084/MJHID.2017.036
Bacterial Blood Stream Infections Negatively Impact on Outcome of Patients Treated with Allogeneic Stem Cell Transplantation: 6 Years Single-Centre Experience
Abstract
Background: Blood stream infections (BSIs) represent a major complication of allo-SCT and are a major cause of morbidity and mortality during and after bone marrow aplasia.
Objectives: The objective of this study was to describe the incidence and outcome of BSIs in a cohort of patients submitted to allo-SCT, in order to track changes of the epidemiology and bacteria resistance.
Methods: We retrospectively analyzed the microbiological data of 162 patients allotransplanted in Brescia University Hospital, over a period of 6 years.
Results: Eighty patients experienced a BSIs for a total of 119 isolates. In 77 cases (65%) a Gram positive bacteria was isolated, being coagulase negative Staphilococci the most frequent species (77% of the cases). In 42 cases (35%) a Gram negative bacteria was isolated (E. coli 57% and P. aeruginosa 24%). Fluoroquinolones resistance was frequent (90% for S. epidermidis, 92% for E. coli, 90% for P. aeruginosa). Methycillin resistance of S. epidermidis was 100%, 76% of E. coli were ESBL positive and among P. aeruginosa resistance to carbapenems was 40%. The 2 years overall survival of patients with BSIs vs patients without BSIs was 46% vs 60% (HR1,48, p=0,07). P. aeruginosa and E. coli were the species with the highest mortality (50% and 33%, respectively).
Conclusions: These data confirm that BSIs, mainly sustained by Gram positive bacteria, are frequent in allotransplanted patients (50% of the cases) and may influence the outcome of allotransplanted patients, being antibiotics resistance highly frequent among these bacteria.
Keywords: Antimicrobical Resistance; Bacterial Infections; Bone Marrow Transplantation.
Conflict of interest statement
Competing interests: The authors have declared that no competing interests exist.
Figures
Comment in
-
Clinical Care of Hematological Patients in a Bone Marrow Transplant Unit: Do Human Resources Influence Infection Incidence?Infect Control Hosp Epidemiol. 2017 Sep;38(9):1131-1132. doi: 10.1017/ice.2017.157. Epub 2017 Jul 31. Infect Control Hosp Epidemiol. 2017. PMID: 28758618 No abstract available.
Similar articles
-
Epidemiology and emerging resistance in bacterial bloodstream infections in patients with hematologic malignancies.Infect Dis (Lond). 2015;47(10):686-93. doi: 10.3109/23744235.2015.1051105. Epub 2015 May 29. Infect Dis (Lond). 2015. PMID: 26024284
-
Epidemiology and microbiology of Gram-negative bloodstream infections in a tertiary-care hospital in Beijing, China: a 9-year retrospective study.Expert Rev Anti Infect Ther. 2021 Jun;19(6):769-776. doi: 10.1080/14787210.2021.1848544. Epub 2020 Dec 3. Expert Rev Anti Infect Ther. 2021. PMID: 33187451
-
Blood stream infections after allogeneic stem cell transplantation: a single-center experience with the use of levofloxacin prophylaxis.Transpl Infect Dis. 2012 Feb;14(1):40-8. doi: 10.1111/j.1399-3062.2011.00650.x. Epub 2011 May 22. Transpl Infect Dis. 2012. PMID: 21599817
-
Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria.Drugs. 2022 Apr;82(5):533-557. doi: 10.1007/s40265-022-01688-1. Epub 2022 Mar 16. Drugs. 2022. PMID: 35294769 Review.
-
Literature review on the distribution characteristics and antimicrobial resistance of bacterial pathogens in neonatal sepsis.J Matern Fetal Neonatal Med. 2022 Mar;35(5):861-870. doi: 10.1080/14767058.2020.1732342. Epub 2020 Feb 26. J Matern Fetal Neonatal Med. 2022. PMID: 32102584 Review.
Cited by
-
Case Report: Late Onset of Myelodysplastic Syndrome From Donor Progenitor Cells After Allogeneic Stem Cell Transplantation. Which Lessons Can We Draw From the Reported Case?Front Oncol. 2020 Oct 14;10:564521. doi: 10.3389/fonc.2020.564521. eCollection 2020. Front Oncol. 2020. PMID: 33178592 Free PMC article.
-
The Applications of Machine Learning in the Management of Patients Undergoing Stem Cell Transplantation: Are We Ready?Cancers (Basel). 2025 Jan 25;17(3):395. doi: 10.3390/cancers17030395. Cancers (Basel). 2025. PMID: 39941764 Free PMC article. Review.
-
Systematic review on epidemiology of Escherichia coli in bloodstream infection of patients undergoing hematopoietic stem cell transplantation.Germs. 2024 Mar 31;14(1):85-94. doi: 10.18683/germs.2024.1420. eCollection 2024 Mar. Germs. 2024. PMID: 39169974 Free PMC article. Review.
-
Results of an Innovative Program for Surveillance, Prophylaxis, and Treatment of Infectious Complications Following Allogeneic Stem Cell Transplantation in Hematological Malignancies (BATMO Protocol).Front Oncol. 2022 Jun 17;12:874117. doi: 10.3389/fonc.2022.874117. eCollection 2022. Front Oncol. 2022. PMID: 35785189 Free PMC article.
References
-
- Marena C, Zecca M, Carenini ML, Bruschi A, Bassi ML, Olivieri P, Azzaretti S, Locatelli F. Incidence of, and risk factors for, nosocomial infections among hematopoietic stem cell transplantation recipients, with impact on procedure-related mortality. Infect Control Hosp Epidemiol. 2001;22:510–7. doi: 10.1086/501942. - DOI - PubMed
-
- Almyroudis NG, Fuller A, Jakubowski A, Sepkowitz K, Jaffe D, Small TN, Kiehn TE, Pamer E, Papanicolaou GA. Pre- and post-engraftment bloodstream infection rates and associated mortality in allogeneic hematopoietic stem cell transplant recipients. Transpl Infect Dis. 2005;7:11–7. doi: 10.1111/j.1399-3062.2005.00088.x. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources